Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is undifferentiated pleomorphic sarcoma (ups)?
Undifferentiated pleomorphic sarcoma (UPS) is one of the most common soft-tissue sarcomas in adults. A sarcoma is a cancer that arises in the body's connective tissues — muscle, fat, fibrous tissue, and the like — rather than in an organ lining. 'Undifferentiated' means the tumor cells are so abnormal that they no longer resemble any specific normal tissue, and 'pleomorphic' refers to how varied and irregular the cells look under the microscope. UPS (formerly called malignant fibrous histiocytoma) most often appears as a deep, painless, gradually enlarging mass in the thigh or another part of an arm or leg, though it can also occur in the trunk, the abdomen, or, sometimes, in skin damaged by previous radiation. Because it can grow quietly and painlessly for a while, any soft-tissue lump that is deep, larger than a few centimeters, or growing should be evaluated and biopsied rather than assumed to be harmless. UPS is generally a high-grade cancer, meaning its cells are aggressive and it can grow and spread relatively quickly; when it spreads, it travels most often to the lungs. The defining challenge in treating it is that, like other soft-tissue sarcomas, it pushes microscopic fingers of tumor into the surrounding tissue well beyond the firm visible mass — which is exactly why treatment pairs surgery with radiation. The modern goal is to cure the cancer while preserving the limb and its function: surgeons remove the tumor with a margin of healthy tissue, and radiation treats the wider area of microscopic disease so the limb can be kept and the chance of the cancer returning is reduced. Chemotherapy is considered in selected higher-risk situations and for disease that has spread.
The main types
Doctors group undifferentiated pleomorphic sarcoma (ups) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Extremity UPS | The most common location — a deep mass in the thigh, leg, or arm; treated with limb-sparing surgery and radiation, with excellent rates of keeping the limb. |
| Retroperitoneal / abdominal UPS | A tumor deep in the back of the abdomen, where it can grow large before causing symptoms; surgery is the mainstay and radiation is used more selectively because of nearby organs. |
| Radiation-associated UPS | An uncommon sarcoma that can arise years after radiation given for a previous cancer; treated with surgery and a careful, individualized plan since the area was treated before. |
| Superficial (cutaneous) UPS | A less common form arising in or just under the skin, generally lower-risk than the deep form and often managed with surgery, sometimes plus radiation. |
Staging, in plain terms
Undifferentiated pleomorphic sarcoma is staged with the TNM system used for soft-tissue sarcomas, but with one feature that carries unusual weight: the grade. Grade describes how aggressive the cells look under the microscope and how quickly the tumor is likely to grow and spread; UPS is usually high-grade, which raises the stakes. The T category reflects the size of the tumor and, for limb and trunk sarcomas, its depth — larger tumors are higher T and carry more risk. The N category notes whether the cancer has reached lymph nodes, which is uncommon for this type, and the M category notes spread to distant organs — for UPS, that overwhelmingly means the lungs, which is why a CT scan of the chest is part of the work-up. Putting size, grade, and spread together sorts patients into stages that predict outcome and shape treatment intensity. In practice, the most important questions the team asks are how big and deep the tumor is, what its grade is, where it sits relative to nerves and major blood vessels (which affects whether the limb can be preserved), and whether it has spread to the lungs. These answers determine the order and combination of surgery, radiation, and — in selected higher-risk cases — chemotherapy. Because UPS spreads through the bloodstream rather than reliably through lymph nodes, staging emphasizes the primary tumor and the lungs rather than nodal mapping.
| Soft-tissue sarcoma TNM with grade — tumor size and depth (T), lymph nodes (N), distant spread (M), plus the tumor grade, which is especially important | What it generally means |
|---|---|
| Localized, smaller (lower stage) | A tumor confined to its site of origin and relatively small; treated with limb-sparing surgery and radiation, with a good chance of cure. |
| Localized, larger or deeper high-grade | A bigger, deep, high-grade tumor still confined locally; treated with surgery and radiation, with chemotherapy considered to lower the risk of later spread. |
| Locally advanced | A tumor closely involving nerves, major vessels, or bone; treated with radiation and surgery planned together to remove it while preserving the limb when possible. |
| Metastatic (usually lungs) | Cancer that has spread, most often to the lungs; treated with systemic therapy, with surgery or focused radiation to remove or control limited deposits in selected patients. |
The standard of care
Undifferentiated Pleomorphic Sarcoma (UPS) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Limb-sparing surgery
Removing the tumor with a margin of healthy tissue while preserving the limb and as much function as possible — the central treatment, and the goal in the great majority of extremity cases.
Radiation therapy (before or after surgery)
Given alongside surgery to treat the microscopic disease that extends beyond the visible tumor; it allows smaller operations that keep the limb and substantially lowers the chance of local recurrence.
Chemotherapy (selected cases)
Considered for large, high-grade tumors at higher risk of spreading, and used for disease that has already spread, to control the cancer throughout the body.
Chest imaging and surveillance
Because UPS tends to spread to the lungs, CT scans of the chest are part of staging and follow-up, so any spread can be found and treated early.
Sarcoma specialty center care
Treatment at a center with a dedicated sarcoma team — combining surgery, radiation, and medical oncology — gives the best chance of cure and limb preservation.
How radiation treatment works
Radiation therapy treats undifferentiated pleomorphic sarcoma by delivering focused beams of energy that damage the DNA inside the tumor cells so they can no longer grow and divide. The reason radiation is such a standard partner to surgery here comes straight from how soft-tissue sarcomas grow: rather than staying neatly within the firm, visible mass, they push microscopic fingers of tumor into the surrounding muscle and connective tissue well beyond what can be seen or felt. If a surgeon removed only the visible tumor, those microscopic extensions could be left behind and seed a recurrence. Radiation solves this by treating a wider zone around the tumor, sterilizing the microscopic disease so the limb can be preserved and the cancer is far less likely to come back locally. There are two main ways to combine radiation with surgery. Given before surgery (preoperative), radiation uses a smaller treatment area and a lower dose and can make a limb-sparing operation safer and gentler on the limb's long-term function, though it requires extra attention to wound healing afterward. Given after surgery (postoperative), radiation treats the tumor bed using a larger area and a higher dose. Both approaches achieve excellent local control, and the choice is tailored to the tumor's size, location, and the surgical plan. Because the goal in the limb is to cure the cancer while keeping the limb working, modern techniques such as intensity-modulated radiation shape the dose tightly around the target to spare the surrounding muscle, bone, and joints. Radiation also has a role beyond the original site: when UPS spreads to a limited number of spots in the lungs, focused high-dose radiation (stereotactic body radiation) can ablate those deposits and provide durable control without surgery. In all of these settings, radiation's strength is treating disease that extends beyond, or has traveled past, the reach of the scalpel — which is precisely the challenge that this aggressive, infiltrating sarcoma presents.
The main ways radiation is delivered for undifferentiated pleomorphic sarcoma (ups):
Preoperative (neoadjuvant) radiation
Radiation given before surgery shrinks the margin of microscopic disease and uses a smaller treatment area and lower dose, which can make a limb-sparing operation safer and is associated with less long-term stiffness — at the cost of more wound-healing care.
Postoperative (adjuvant) radiation
Radiation to the tumor bed after surgery, used when preoperative radiation wasn't given, treats microscopic disease left behind and lowers the chance of local recurrence; it covers a larger area at a higher dose.
Intensity-modulated radiation (IMRT)
Shaping the beams tightly around the target spares surrounding muscle, bone, and joints, helping preserve limb function while delivering a full dose to the tumor bed.
Stereotactic body radiation (SBRT) for metastases
Focused, high-dose radiation can ablate a limited number of lung metastases, offering durable control of oligometastatic disease without surgery.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Radiation plus limb-sparing surgery preserves limbs and controls disease: Landmark trials established that combining radiation with limb-sparing surgery gives local control equal to amputation for extremity soft-tissue sarcomas, allowing most patients to keep a functional limb — the foundation of modern UPS treatment.[1]
Limb-sparing surgery plus radiotherapy sarcoma trials
Preoperative versus postoperative radiation trade-offs: Randomized data show preoperative radiation uses a smaller field and lower dose with better long-term limb function but more wound complications, while postoperative radiation has fewer wound problems but more late stiffness — guiding individualized timing.[2]
Pre- versus post-operative radiotherapy randomized trial (extremity sarcoma)
Stereotactic radiation controls lung metastases: Studies of stereotactic body radiation for a limited number of sarcoma lung metastases report high rates of local control, supporting focused radiation as an option for oligometastatic disease alongside or instead of surgery.[3]
SBRT for sarcoma pulmonary metastases series
Common questions
Will I lose my limb? Almost always, no. The modern standard for sarcomas in an arm or leg is limb-sparing treatment: the surgeon removes the tumor with a margin of healthy tissue, and radiation treats the wider area of microscopic disease so the limb can be kept. This approach controls the cancer as well as amputation did in the past, and the great majority of people keep a functional limb. Amputation is reserved for the uncommon tumor that can't be removed any other way.
Why do I need radiation if the surgeon removes the tumor? Because soft-tissue sarcomas like UPS send microscopic fingers of tumor into the surrounding tissue beyond the visible mass. Surgery removes the mass and a margin, but radiation treats the wider zone of microscopic disease that can't all be cut out without sacrificing the limb. Combining the two lets surgeons do a smaller, limb-preserving operation while keeping the chance of the cancer returning locally low. Radiation can be given before or after surgery, each with its own trade-offs.
Where does UPS spread, and how is that watched for? When undifferentiated pleomorphic sarcoma spreads, it travels through the bloodstream and most often goes to the lungs; spread to lymph nodes is uncommon. That's why a CT scan of the chest is part of the initial work-up and of follow-up. If a limited number of lung deposits appear, they can sometimes be removed surgically or treated with focused, high-dose radiation, and more widespread disease is treated with medication.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Limb-sparing surgery plus radiotherapy sarcoma trials (no indexed identifier — see your care team) ↩
- Pre- versus post-operative radiotherapy randomized trial (extremity sarcoma) (no indexed identifier — see your care team) ↩
- SBRT for sarcoma pulmonary metastases series (no indexed identifier — see your care team) ↩